Conference News

NORTH READING, Mass.--(BUSINESS WIRE)--Teradyne will exhibit its latest innovations at the 2026 IESA Vision Summit, 25-26 February at the Leela Bhartiya City Convention Centre in Bengaluru....

SAN FRANCISCO--(BUSINESS WIRE)--Ambience Healthcare, the leading intelligence platform for clinical documentation and revenue integrity, today announced it has been named the 2026 KLAS/CHIME Trailblazer Award winner. Now in its second year, the Trailblazer Award recognizes an emerging vendor demonstrating exceptional leadership in innovation, impact, and client success. Recipients are selected based on outstanding KLAS performance scores, meaningful client feedback, and measurable contributions...

LAS VEGAS--(BUSINESS WIRE)--Strategy (formerly MicroStrategy) officially opened Strategy World 2026 today at The Wynn Las Vegas, welcoming a global audience of executives and data pioneers to the year’s definitive summit on Digital Sovereignty. Running through February 26, the event—held alongside the sixth annual Bitcoin for Corporations—is designed to bridge the gap between enterprise AI and corporate treasury. From visionary keynotes to hands-on technology showcases, Strategy World 2026 is w...

SANTA CLARA, Calif.--(BUSINESS WIRE)--PlusAI, a leader in AI software for autonomous trucks, today announced that members of its senior management team are scheduled to participate in the following investor conferences in March. Citizens Technology Conference March 2-3, 2026 San Francisco, CA David Liu, CEO of PlusAI, will be presenting on March 2nd at 12:30pm ET Cantor Fitzgerald Technology Conference March 10-11, 2026 New York, NY Shawn Kerrigan, COO of PlusAI, will be speaking on an Autonomo...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced new data from the ongoing Phase 1 clinical trial of VIR-5500, a prostate-specific membrane antigen (PSMA)-targeting, PRO-XTEN® dual-masked T-cell engager (TCE) being evaluated in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) who have progressed after multiple lines of therapy (NCT05997615). These data suggest that VIR-5500 monotherapy is well tolerated and exhibits promising an...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases, today announced a new analysis of efficacy and biomarker data for casdatifan, a HIF-2a inhibitor with best-in-class potential, in late-line metastatic clear cell renal cell carcinoma (ccRCC) from the Phase 1/1b ARC-20 study. These data will be presented in a post...

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the American Society of Genitourinary Cancers Symposium happening from February 26-28, 2026, in San Francisco, California. Flatiron's real-world data and research capabilities are featured across multiple presentations, including 6 research acceptances spanning genitourinary cancers. A cornerstone of Flatiron’s presence at ASCO GU 2026 is the global prostate cancer and bladder cancer Panoramic datasets, which draw from o...

BOSTON--(BUSINESS WIRE)--Klaviyo (NYSE: KVYO), the autonomous B2C CRM, today announced that Andrew Bialecki, Co-Founder and Co-CEO, Chano Fernandez, Co-CEO, and Amanda Whalen, CFO, will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, March 4, 2026 at 5:35 p.m. ET / 2:35 p.m. PT. Live webcasts and replays will be available on Klaviyo’s investor relations website at https://investors.klaviyo.com/. About Klaviyo Klaviyo (CLAY-vee-oh) is...

PASADENA, Calif.--(BUSINESS WIRE)--Dine Brands Global, Inc. (NYSE: DIN), the parent company of Applebee's Neighborhood Grill + Bar®, IHOP® and Fuzzy’s Taco Shop® restaurants, today announced it will participate in two investor conferences in March. The Company will meet with institutional investors and host a fireside chat at 2:15 p.m. ET at the Raymond James & Associates’ 47th Annual Institutional Investors Conference on Monday, March 2, 2026 in Orlando. The Company will meet with institut...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chief Executive Officer, will present at the Leerink Partners Global Healthcare Conference on Monday, Mar. 9, 2026. The Company's presentation will begin at 1:40 p.m. (ET). A live we...